Victor Levitsky

2.5k total citations · 1 hit paper
41 papers, 1.9k citations indexed

About

Victor Levitsky is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Victor Levitsky has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 20 papers in Immunology and 14 papers in Epidemiology. Recurrent topics in Victor Levitsky's work include Viral-associated cancers and disorders (17 papers), Immune Cell Function and Interaction (15 papers) and Cytomegalovirus and herpesvirus research (12 papers). Victor Levitsky is often cited by papers focused on Viral-associated cancers and disorders (17 papers), Immune Cell Function and Interaction (15 papers) and Cytomegalovirus and herpesvirus research (12 papers). Victor Levitsky collaborates with scholars based in Sweden, United States and Spain. Victor Levitsky's co-authors include Maria G. Masucci, Jelena Levitskaya, Michael G. Kurilla, Stefan Imreh, George Klein, Teresa Frisan, Pedro O. de Campos‐Lima, Olle Ringdén, Jie‐Zhi Zou and Jacek Winiarski and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Victor Levitsky

38 papers receiving 1.9k citations

Hit Papers

Inhibition of antigen processing by the internal repeat r... 1995 2026 2005 2015 1995 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1
    1995 634 citations Jelena Levitskaya, Victor Levitsky et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victor Levitsky Sweden 17 1.2k 890 625 377 312 41 1.9k
I S Misko Australia 27 1.5k 1.3× 1.6k 1.8× 934 1.5× 515 1.4× 309 1.0× 49 2.6k
Paula S. Norris United States 20 493 0.4× 1.1k 1.2× 510 0.8× 174 0.5× 528 1.7× 30 2.0k
Ayumi Kudoh Japan 26 975 0.8× 271 0.3× 847 1.4× 167 0.4× 540 1.7× 35 1.7k
Hiroki Isomura Japan 28 1.1k 0.9× 335 0.4× 1.3k 2.1× 163 0.4× 602 1.9× 52 2.1k
J. R. Arrand United Kingdom 24 974 0.8× 308 0.3× 855 1.4× 290 0.8× 365 1.2× 39 1.8k
John Yates United States 13 1.3k 1.1× 366 0.4× 846 1.4× 368 1.0× 719 2.3× 23 2.4k
John L. Yates United States 20 1.4k 1.2× 357 0.4× 888 1.4× 471 1.2× 841 2.7× 22 2.3k
S. Finerty United Kingdom 22 948 0.8× 361 0.4× 460 0.7× 473 1.3× 137 0.4× 36 1.3k
M Heller United States 21 1.0k 0.9× 462 0.5× 526 0.8× 464 1.2× 301 1.0× 29 1.7k
Nikolaus Mueller‐Lantzsch Germany 32 735 0.6× 483 0.5× 881 1.4× 296 0.8× 1.1k 3.5× 63 2.8k

Countries citing papers authored by Victor Levitsky

Since Specialization
Citations

This map shows the geographic impact of Victor Levitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Levitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Levitsky more than expected).

Fields of papers citing papers by Victor Levitsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Levitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Levitsky. The network helps show where Victor Levitsky may publish in the future.

Co-authorship network of co-authors of Victor Levitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Levitsky. A scholar is included among the top collaborators of Victor Levitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Levitsky. Victor Levitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ponce, Santiago, S. Cedrés, Charles Ricordel, et al.. (2023). ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment. Journal for ImmunoTherapy of Cancer. 11(9). e007552–e007552. 16 indexed citations
2.
Rigamonti, Nicolò, Niina Veitonmäki, Francesca Malvezzi, et al.. (2022). A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression. Cancer Immunology Research. 10(5). 626–640. 18 indexed citations
3.
Schoutrop, Esther, Anette Mörtberg, Mischa Müller, et al.. (2020). Profound Functional Suppression of Tumor‐Infiltrating T‐Cells in Ovarian Cancer Patients Can Be Reversed Using PD‐1‐Blocking Antibodies or DARPin® Proteins. Journal of Immunology Research. 2020(1). 7375947–7375947. 9 indexed citations
4.
Levitsky, Victor, et al.. (2019). Abstract B026: Development of tumor-targeted agonistic Immunomodulators using the DARPin® technology platform. Cancer Immunology Research. 7(2_Supplement). B026–B026. 1 indexed citations
5.
Rigamonti, Nicolò, Anja Schlegel, Susanne Mangold, et al.. (2019). Abstract 3251: Fibroblast activation protein (FAP)-selective delivery of CD40 agonistic DARPin®molecule for tumor-localized immune activation. Cancer Research. 79(13_Supplement). 3251–3251. 1 indexed citations
6.
Hepp, Julia, Christian Reichen, Alexander Titz, et al.. (2018). Abstract 3752: Preclinical pharmacology of MP0310: A 4-1BB/FAP bispecific DARPin drug candidate promoting tumor-restricted T-cell costimulation. Cancer Research. 78(13_Supplement). 3752–3752. 3 indexed citations
7.
8.
Ma, Jinxia, André Ortlieb Guerreiro‐Cacais, Eva Rudd, et al.. (2011). Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to colocalize with cytotoxic granules. Journal of Cellular and Molecular Medicine. 16(1). 129–141. 25 indexed citations
9.
Chêne, Arnaud, Daria Donati, André Ortlieb Guerreiro‐Cacais, et al.. (2007). A Molecular Link between Malaria and Epstein–Barr Virus Reactivation. PLoS Pathogens. 3(6). e80–e80. 131 indexed citations
10.
Schaft, Niels, Joost Drexhage, Cor Berrevoets, et al.. (2006). T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNγ production. International Immunology. 18(4). 591–601. 40 indexed citations
11.
Pavlenko, Maxim, Christoph Leder, Anna‐Karin Roos, Victor Levitsky, & Pavel Pisa. (2005). Identification of an immunodominant H‐2Db‐restricted CTL epitope of human PSA. The Prostate. 64(1). 50–59. 20 indexed citations
12.
Levitsky, Victor, Teresa Frisan, & Maria G. Masucci. (2003). Determination of Antigen and Fine Peptide Specificity of EBV-Specific CTLs. Humana Press eBooks. 174. 209–211.
13.
Frisan, Teresa, Victor Levitsky, & Maria G. Masucci. (2003). Limiting Dilution Assay. Humana Press eBooks. 174. 213–216. 10 indexed citations
14.
Frisan, Teresa, Victor Levitsky, & Maria G. Masucci. (2003). Generation of Lymphoblastoid Cell Lines (LCLs). Humana Press eBooks. 174. 125–127. 22 indexed citations
15.
Levitsky, Victor, Teresa Frisan, & Maria G. Masucci. (2003). Generation of Polyclonal EBV-Specific CTL Cultures and Clones. Humana Press eBooks. 174. 203–208. 2 indexed citations
16.
Carlens, Stefan, Olle Ringdén, J Aschan, et al.. (2002). Cytolytic T Cell Reactivity to Epstein-Barr Virus Is Lost During In Vitro T Cell Expansion. Journal of Hematotherapy & Stem Cell Research. 11(4). 669–674. 9 indexed citations
17.
Levitsky, Victor & Maria G. Masucci. (2002). Manipulation of immune responses by Epstein–Barr virus. Virus Research. 88(1-2). 71–86. 27 indexed citations
18.
19.
Levitskaya, Jelena, Victor Levitsky, Stefan Imreh, et al.. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1. Nature. 375(6533). 685–688. 634 indexed citations breakdown →
20.
Campos‐Lima, Pedro O. de, Victor Levitsky, Jill Brooks, et al.. (1994). T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.. The Journal of Experimental Medicine. 179(4). 1297–1305. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I S Misko Breakdown of academic impact, for papers by Paula S. Norris Breakdown of academic impact, for papers by Ayumi Kudoh Breakdown of academic impact, for papers by Hiroki Isomura Breakdown of academic impact, for papers by J. R. Arrand Breakdown of academic impact, for papers by John Yates Breakdown of academic impact, for papers by John L. Yates Breakdown of academic impact, for papers by S. Finerty Breakdown of academic impact, for papers by M Heller Breakdown of academic impact, for papers by Nikolaus Mueller‐Lantzsch
Rankless by CCL
2026